Taro Pharmaceutical (TAROF) Posts Q4, FY 2011 Preliminary Financial Results
Taro Pharmaceutical Industries Ltd., a multinational science-based pharmaceutical company, today provided unaudited financial results for the quarter and full year ended December 31, 2011. Fourth-quarter revenues for 2011 were $148.1 million, a 44.3 percent increase over fourth-quarter revenue for 2010. Gross profit as a percentage of net sales was 71.6 percent, compared to 59.6 percent. Fourth quarter 2011 operating income of $74.5 million, or 50.3 percent of net sales, represents a significant increase compared to $21.6 million, or 21.0 percent of net sales, reported for the comparable quarter of 2010. Net income for the fourth quarter of 2011 was negatively…